Concepedia

Biologics Compatibility

Biologics Compatibility is a packaging compatibility framework that specifies the conditions under which biological products maintain their structural integrity, functional activity, and safety when in contact with packaging materials throughout storage and delivery.

7

Publications

240

Citations

52

Authors

34

Institutions

Publications per year

2017–2026

3

Parents

Publications

7

Biosimilar epoetins and other “follow‐on” biologics: Update on the European experiences

Wolfgang Jelkmann · American Journal of Hematology · 2010 · 93 citations · Full text

, , +14

Biosimilars in rheumatology: what the clinician should know

Gilberto Castañeda‐Hernández, Rodrigo González‐Ramírez, Jonathan Kay et al. · RMD Open · 2015 · 46 citations · Full text

, , +17

An Industry Perspective on Compatibility Assessment of Closed System Drug-Transfer Devices for Biologics

Ahmed Besheer, Lori Burton, Richard J. Galas et al. · Journal of Pharmaceutical Sciences · 2020 · 32 citations · Full text

, , +12

Biologic compatibility and applications of hydron.

Bernard S. Levowitz, Joseph N. LaGuerre, William S. Calem et al. · PubMed · 1968 · 23 citations

, , +6

Ophthalmic biosimilars and biologics—role of endotoxins

Ashish Sharma, Nilesh Kumar, Baruch D. Kuppermann et al. · Eye · 2019 · 20 citations · Full text

, , +7

1–5 of 7

Authors

52

  1. LN
    Ly Ngo

    Jefferson College, United States

    1 publications · 13 citations

    1

    h-index

  2. BS
    Bernard S. Levowitz

    State University of New York, United States

    1 publications · 23 citations

    1

    h-index

  3. BD
    Baruch D. Kuppermann

    University of California, Irvine, United States

    1 publications · 20 citations

    1

    h-index

  4. SS
    S. Schier-Mumzhiu

    Sanden (Japan), Japan

    1 publications · 13 citations

    1

    h-index

  5. JS
    Joseph Scherrer

    Washington University Medical Center, United States

    1 publications · 23 citations

    1

    h-index

1–5 of 52

Institutions

34

  1. Novartis (United States)

    New York, United States

    2 h-index

    3 publications

    39 citations

  2. Celerion (United States)

    Lincoln, United States

    1 h-index

    2 publications

    26 citations

  3. UMass Memorial Medical Center

    Worcester, United States

    1 h-index

    1 publications

    46 citations

  4. Janssen (United States)

    Hopewell, United States

    1 h-index

    3 publications

    96 citations

  5. Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional

    Mexico City, Mexico

    1 h-index

    2 publications

    92 citations

  6. Hexal (Germany)

    Holzkirchen, Germany

    1 h-index

    7 publications

    91 citations

  7. Merck & Co., Inc., Rahway, NJ, USA (United States)

    Rahway, United States

    1 h-index

    1 publications

    32 citations

  8. Bristol-Myers Squibb (United States)

    New York, United States

    1 h-index

    1 publications

    32 citations

1–8 of 34

Venues

  1. RMD Open

    1 publications · 46 citations

    1

    h-index

  2. Clinical Pharmacology & Therapeutics

    CPT · 1 publications · 13 citations

    1

    h-index

  3. PubMed

    Repository · 1 publications · 23 citations

    1

    h-index

  4. British Journal of Clinical Pharmacology

    BJCP · 1 publications · 13 citations

    1

    h-index

  5. Journal of Pharmaceutical Sciences

    1 publications · 32 citations

    1

    h-index

1–5